Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Kiora Pharmaceuticals, Inc.’s names, not what it holds today.
Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
11
since 2001, to Dec 31, 2025
Names they are printed under
2
a former name
By yearGrantedApplications published
'09'11'12'15'16'17'18'19'20'21
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
EyeGate Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
8 publishedEyeGate Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
3 publishedNames not counted (2)
KIORA PHARMACEUTICALS INC
Most of its patents print AT; this name counts in US. 0 granted and 6 published under it are not counted.
KIORA PHARMACEUTICALS INC
Most of its patents print AT; this name counts in US. 4 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Aug 13, 2019 | 10,376,463 | Ocular iontophoretic delivery of dexamethasone and formulations thereof | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
| Apr 10, 2018 | 9,937,074 | Iontophoretic contact lens | Medical technology | EyeGate Pharmaceuticals, Inc. |
| Nov 21, 2017 | 9,820,935 | Delivery of corticosteroids through iontophoresis | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
| Jan 10, 2017 | 9,539,141 | System and method for ocular iontophoresis with buffering | Medical technology | EyeGate Pharmaceuticals, Inc. |
| Nov 10, 2015 | 9,180,292 | System and method for ocular iontophoresis with buffering | Medical technology | EyeGate Pharmaceuticals, Inc. |
| Oct 6, 2015 | 9,149,525 | Delivery of corticosteroids through iontophoresis | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Sep 30, 2021 | 2021/0299039 | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
| Sep 23, 2021 | 2021/0290527 | Compositions and Methods for Treatment of Ocular Conditions | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
| Nov 5, 2020 | 2020/0345634 | Compositions and Methods for Treatment of Ocular Diseases | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. · patent 11,376,214 granted from it |
| Sep 15, 2016 | 2016/0263024 | DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. · patent 9,820,935 granted from it |
| Jul 28, 2016 | 2016/0213514 | IONTOPHORETIC CONTACT LENS | Medical technology | EyeGate Pharmaceuticals, Inc. · patent 9,937,074 granted from it |
| May 5, 2016 | 2016/0120696 | SYSTEN AND METHOD FOR OCULAR IONTOPHORESIS WITH BUFFERING | Medical technology | EyeGate Pharmaceuticals, Inc. · patent 9,539,141 granted from it |
| Nov 8, 2012 | 2012/0283231 | Delivery Of Corticosteroids Through Iontophoresis | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. · patent 10,376,463 granted from it |
| Sep 6, 2012 | 2012/0225834 | OCULAR IONTOPHORESIS OF CHARGED MICELLES CONTAINING BIOACTIVE AGENTS | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
| Jul 12, 2012 | 2012/0177741 | POSITIVELY-CHARGED POLY (D,L-LACTIDE-CO-GLYCOLIDE) NANOPARTICLES AND FABRICATION METHODS OF THE SAME | Pharmaceuticals | EyeGate Pharmaceuticals, Inc. |
| Dec 8, 2011 | 2011/0301526 | SYSTEM AND METHOD FOR OCULAR IONTOPHORESIS WITH BUFFERING | Medical technology | EyeGate Pharmaceuticals, Inc. · patent 9,180,292 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.